Literature DB >> 1567043

Effect of sevoflurane on diaphragmatic contractility in dogs.

T Ide1, T Kochi, S Isono, T Mizuguchi.   

Abstract

The effect of sevoflurane on diaphragmatic contractility was investigated in 12 anesthetized, mechanically ventilated dogs with the thorax opened. Animals were divided into two groups of six each: the sevoflurane and time control groups. We assessed contractility by the transdiaphragmatic pressure (Pdi) during supramaximal stimulation of the phrenic nerve at frequencies of 0.5, 10, 20, 50, and 100 Hz under quasiisometric conditions. The integrated electrical activity (Edi) of the crural and costal parts of the diaphragm (Edi cru, Edi cost) was also measured. In the sevoflurane group, diaphragmatic contractility was determined during three levels of anesthesia, specifically 0, 1.0, and 1.5 minimum alveolar anesthetic concentration (MAC). Measurements were made at the start of the stimulation (initial) and at the end of the 2-s period (2-s). Increasing the depth of sevoflurane anesthesia did not cause any significant differences in Pdi and Edi at 0.5-, 10-, and 20-Hz stimulation. By contrast, at 50- and 100-Hz stimulation, initial Pdi during 1.0 and 1.5 MAC sevoflurane exposure decreased significantly compared with the 0 MAC value (P less than 0.05). In addition, there was a statistical difference in 2-s Pdi between 1.0 and 1.5 MAC at 100-Hz stimulation (P less than 0.05). The Edi cru showed similar changes in Pdi at both measurements, whereas there was no remarkable change in Edi cost. There was no significant change either in Pdi or in Edi with respect to time in the time control group. We conclude from these results that sevoflurane impairs diaphragmatic contractility through its inhibitory effect on neuromuscular transmission, predominantly of the crural part.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1567043     DOI: 10.1213/00000539-199205000-00020

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  12 in total

1.  Effects of milrinone and olprinone on hypercapnic depression of diaphragmatic contractility in pentobarbital-anesthetized dogs.

Authors:  Yoshitaka Fujii; Aki Uemura
Journal:  Curr Ther Res Clin Exp       Date:  2007-05

2.  Effects of dibutyryl cyclic adenosine monophosphate on hypercapnic depression of diaphragmatic contractility in pentobarbital-anesthetized dogs.

Authors:  Yoshitaka Fujii; Aki Uemura
Journal:  Curr Ther Res Clin Exp       Date:  2010-06

3.  Effects of diazepam on diaphragmatic functionand recovery in pentobarbital-anesthetized dogs: An open-label, dose-finding, pharmacologic study.

Authors:  Yoshitaka Fujii
Journal:  Curr Ther Res Clin Exp       Date:  2005-07

4.  Olprinone/dopamine combination for improving diaphragmatic fatigue in pentobarbital-anesthetized dogs.

Authors:  Yoshitaka Fujii
Journal:  Curr Ther Res Clin Exp       Date:  2006-05

Review 5.  Sevoflurane. A review of its pharmacodynamic and pharmacokinetic properties and its clinical use in general anaesthesia.

Authors:  S S Patel; K L Goa
Journal:  Drugs       Date:  1996-04       Impact factor: 9.546

6.  Distribution of diaphragm blood flow during sevoflurane anaesthesia in dogs.

Authors:  T Ide; T Kochi; K Iijima; T Mizuguchi
Journal:  Can J Anaesth       Date:  1996-01       Impact factor: 5.063

7.  Treatment of diaphragmatic fatigue with inhaled aminophylline therapy in an experimental canine model: an open-label, dose-ranging, pharmacologic study.

Authors:  Yoshitaka Fujii
Journal:  Curr Ther Res Clin Exp       Date:  2003-11

8.  Dose-related effects of olprinone on hypercapnia-Induced impairment of diaphragmatic contractility in pentobarbital-anesthetized dogs.

Authors:  Yoshitaka Fujii; Aki Uemura
Journal:  Curr Ther Res Clin Exp       Date:  2008-06

9.  Amrinone improves contractility of fatigued diaphragm in dogs.

Authors:  Y Fujii; H Toyooka; K Amaha
Journal:  Can J Anaesth       Date:  1995-01       Impact factor: 5.063

Review 10.  Sevoflurane.

Authors:  Stefan De Hert; Anneliese Moerman
Journal:  F1000Res       Date:  2015-08-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.